J-Valve study for leaky aortic valve patients
Part of Heart & circulation clinical trials.
This study tests a new, less invasive device called J-Valve for people with severe aortic regurgitation (a leaky aortic valve). It is placed through a tube in the leg artery, avoiding open-heart surgery, and may help those who are at high risk for surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe aortic regurgitation (a leaky heart valve) and have symptoms like shortness of breath or fatigue.
- Your heart team has decided that standard surgery would be too risky for you.
- Your valve anatomy is suitable for the J-Valve device (doctors will check with imaging).
- You have not had a previous aortic valve replacement surgery.
- You do not have severe other heart valve problems, active infections, or advanced kidney/liver disease.
- Your heart function is not too weak (ejection fraction greater than 25%).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device to fix a leaky aortic valve in people who already have a mechanical heart pump (LVAD). The goal is to help the pump work better and reduce symptoms.
This study tests a new replacement valve for the aortic valve, which controls blood flow from the heart. It may help people with severe aortic valve narrowing or leaking who need surgery.
This trial tests a new, less invasive device called the AltaValve to treat a leaky mitral valve. It is for people whose leak is severe enough to cause symptoms, but who cannot have standard surgery or a clip procedure.
This trial compares a new catheter-based valve (J-Valve) with open-heart surgery for people with severe aortic regurgitation, a condition where the aortic valve doesn't close tightly. It aims to see which treatment is safer and more effective.
This study is for people with a severe leaking aortic valve (aortic regurgitation) who are too high-risk for open-heart surgery. It tracks how well a less-invasive valve replacement (TAVI) using the JenaValve or J-Valve works for them.
This trial studies a less invasive heart valve procedure that places a new valve through a catheter, to treat severe leakage of the aortic valve. It may help people who have symptoms or heart enlargement and who are at higher risk for open-heart surgery.
Hear when a new Aortic Valve Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.